Skip to Main Content

Paper Details

Mutation Clearance after Transplantation for Myelodysplastic Syndrome.
N Engl J Med
90
2018
Leukemia, Lymphoma, MDS, Myelodysplastic Syndrome, Patients, hematopoietic stem-, hematopoietic stem-cell, heterozygous mutant cell, myelodysplastic syndrome, patients, variant allele
Author NameAffiliation
Christopher A Millerthe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Robert S Fultonthe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Robert S Fultonthe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Catrina Fronickthe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Michelle O'Laughlinthe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Sharon E Heaththe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Lukas D Wartmanthe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Matthew J Christopherthe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Daniel C Linkthe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
John F DiPersiothe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Peter Westerveltthe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Timothy J Leythe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Timothy A Graubertthe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
Matthew J Walterthe McDonnell Genome Institute (G.S.C., Division of Hospital Medicine (R.S.), Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis and Massachusetts General Hospital Cancer Center
  • 1 - 14

Datasets

Release 1.2